With a market capitalization (market cap) of $31.91B — a measure of how much the company is worth — ResMed Inc. is the 448th most valuable company in Healthcare as of August 18, 2026. Shares trade at $219.98, down +0.18% on the day.
of 2,587
price ÷ annual EPS
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
FY 2026
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
Visit websiteAs of August 18, 2026, ResMed Inc. (RMD) is worth $31.91B — this is its market capitalization, the total value of all its outstanding shares.
ResMed Inc.’s market cap is $31.91B, which ranks it #448 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
ResMed Inc. (RMD) shares trade at $219.98, down 0.18% on the day, as of August 18, 2026.
ResMed Inc. trades at a price-to-earnings (P/E) ratio of 21.1, based on its latest share price and annual earnings per share.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2026